Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Prospective Clinical Trials of Thyroidectomy With LigaSure vs Conventional Vessel Ligation

Prospective Clinical Trials of Thyroidectomy With LigaSure vs Conventional Vessel Ligation REVIEW ARTICLE Prospective Clinical Trials of Thyroidectomy With LigaSure vs Conventional Vessel Ligation A Systematic Review and Meta-analysis Hou Shan Yao, MD; Qiang Wang, MD; Wei Jun Wang, MD; Can Ping Ruan, MD Objective: To evaluate the hemostatic effects and safety tomy. Operative duration (weighted mean difference of thyroidectomy performed using the LigaSure vessel- [WMD], –11.97 minutes; 95% confidence interval [CI], sealing device (Valleylab, Boulder, Colorado) or the con- –16.42 to –7.53 minutes) was significantly reduced with ventional vessel ligation. LigaSure thyroidectomy (P.001). When LigaSure was used, operative time reductions of 20.32 minutes (95% CI, Data Sources: The MEDLINE, EMBASE, Elsevier, –33.86 to –6.79 minutes) for total thyroidectomy (P=.003) SpringerLink, Ovid, and Cochrane Library electronic da- and 21.74 minutes (–38.32 to –5.16 minutes) for subto- tabases as well as the LigaSure manufacturer’s Web site tal thyroidectomy (P=.01) were also confirmed with sub- were searched for studies published between 1996 and group analysis. However, differences in the amount of in- 2008. No language restrictions were applied. traoperative blood loss (WMD, –25.13 mL; 95% CI, –68.45 to 18.18 mL; P=.26), length of hospital stay (WMD, –0.08 Study Selection: Prospective, controlled clinical trials, days; 95% CI, –0.23 to 0.08 days; P=.31), and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Surgery American Medical Association

Prospective Clinical Trials of Thyroidectomy With LigaSure vs Conventional Vessel Ligation

JAMA Surgery , Volume 144 (12) – Dec 1, 2009

Loading next page...
 
/lp/american-medical-association/prospective-clinical-trials-of-thyroidectomy-with-ligasure-vs-zw0rZpJ0Fz
Publisher
American Medical Association
Copyright
Copyright 2009 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6254
eISSN
2168-6262
DOI
10.1001/archsurg.2009.201
pmid
20026837
Publisher site
See Article on Publisher Site

Abstract

REVIEW ARTICLE Prospective Clinical Trials of Thyroidectomy With LigaSure vs Conventional Vessel Ligation A Systematic Review and Meta-analysis Hou Shan Yao, MD; Qiang Wang, MD; Wei Jun Wang, MD; Can Ping Ruan, MD Objective: To evaluate the hemostatic effects and safety tomy. Operative duration (weighted mean difference of thyroidectomy performed using the LigaSure vessel- [WMD], –11.97 minutes; 95% confidence interval [CI], sealing device (Valleylab, Boulder, Colorado) or the con- –16.42 to –7.53 minutes) was significantly reduced with ventional vessel ligation. LigaSure thyroidectomy (P.001). When LigaSure was used, operative time reductions of 20.32 minutes (95% CI, Data Sources: The MEDLINE, EMBASE, Elsevier, –33.86 to –6.79 minutes) for total thyroidectomy (P=.003) SpringerLink, Ovid, and Cochrane Library electronic da- and 21.74 minutes (–38.32 to –5.16 minutes) for subto- tabases as well as the LigaSure manufacturer’s Web site tal thyroidectomy (P=.01) were also confirmed with sub- were searched for studies published between 1996 and group analysis. However, differences in the amount of in- 2008. No language restrictions were applied. traoperative blood loss (WMD, –25.13 mL; 95% CI, –68.45 to 18.18 mL; P=.26), length of hospital stay (WMD, –0.08 Study Selection: Prospective, controlled clinical trials, days; 95% CI, –0.23 to 0.08 days; P=.31), and

Journal

JAMA SurgeryAmerican Medical Association

Published: Dec 1, 2009

References